Schwetz B.New Treatment for Chronic Myelogenous Leukemia.The Journal of The American Medical Association. 2001Schwetz BA. New Treatment for Chronic Myelogenous Leukemia. JAMA. 2001; 286:35.Schwetz BA.New treatment for chronic myelogenous leukemia[J].2001,28....
Leukemias are cancers of the blood cells. Chronic myelogenous leukemia (CML) is an uncommon type of cancer of the bone marrow, which produces blood cells. "Myelogenous" refers to the type of blood cells this leukemia affects. "Chronic" means this cancer is more slowly progressing than other s...
The role of interferon in the treatment of chronic myelogenous leukemia: results and prospects. Leukemia and Lymphoma 1992: 6: 305-3 15.MORRA, E., LAZZARINO, M., ALIMENA, G, LIBERATI, A.M., GRIGNANI, F., MANDELLI, F., and BERNASCONI, C. (1992). The role of interferon in the ...
See what to expect with chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, and learn how it's treated. WebMD takes you through the stages, from diagnosis and tests to relapse and remission.
Chronic myeloid leukemia(CML, also known as chronic myelogenous leukemia) is a type of chronic myeloproliferative disorder that primarily affects adults and occurs in about 8,400 people every year in the U.S. Less common types of leukemia account for about 6,000 cases of leukemia each year in...
BACKGROUND: The treatment options for bcr-abl positive chronic myelogenous leukemia (CML) include chemotherapy, immune therapy, allogeneic stem cell transplantation, and molecular therapy. The tyrosine kinase inhibitor imatinib was approved for the treatment of CML in 2002. Data from clinical trials all...
Chronic myelogenous leukemia (CML) involves the clonal expansion of hemopoietic progenitor cells associated with a characteristic translocation between chromosomes 9 and 22, resulting in the generation of an aberrant bcr-abl protein with enhanced tyrosine kinase activity. Although the precise molecular event...
(FDA) in 2001 for the treatment of chronic myelogenous leukemia (CML), a rare form ofcancerthat affects certain types of white blood cells. Since its initial approval, Gleevec has also been approved for use in patients with several types of gastrointestinal tumors. Currently, scientists continue...
At the present time, the use of busulfan in chronic phase CML patients should be limited to those patients who are intolerant of or resistant to hydroxyurea therapy. Busulfan is an oral alkylating agent. It is an inexpensive medication and typically provides long periods of hematologic control, ...
Leukemias arising from lymphocytes are called lymphocytic leukemias; those from granulocytes are called myeloid, or myelogenous, leukemias.Leukemia is either acute (comes on suddenly) or chronic (lasts a long time). Also, the type of leukemic cell determines whether it is an acute leukemia or ...